Mary E. Bradley
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 2
- Amoebic Infections and Treatments 1
-
- Fungal Infections and Studies 2
- Co-authors
- Oliver H. Lowry (1 shared paper)Helen B. Burch (1 shared paper)Peter G. Pappas (2 shared papers)Virginia L. Kan (1 shared paper)Daniel H. Kett (1 shared paper)William E. Dismukes (1 shared paper)Barbara D. Alexander (1 shared paper)Samuel Major (1 shared paper)
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)Journal of Biological Chemistry (1 paper)Cellular and Molecular Life Sciences (1 paper)Canadian Journal of Microbiology (1 paper)Annals of Epidemiology (1 paper)
- Partner nations
- United StatesBrazilUnited Kingdom
In The Last Decade
Mary E. Bradley
11 papers receiving 460 citations
Peers
Comparison fields: 5 of 86
- Applied Microbiology and Biotechnology 47
- Infectious Diseases 265
- Clinical Biochemistry 48
- Epidemiology 176
- Critical Care and Intensive Care Medicine 18
Countries citing papers authored by Mary E. Bradley
This map shows the geographic impact of Mary E. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Bradley more than expected).
Fields of papers citing papers by Mary E. Bradley
This network shows the impact of papers produced by Mary E. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Bradley. The network helps show where Mary E. Bradley may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary E. Bradley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 278 | |
| 2 | 1967 | 96 | |
| 3 | 1996 | 29 | |
| 4 | 1998 | 23 | |
| 5 | 2020 | 15 | |
| 6 | 1996 | 12 | |
| 7 | 2019 | 9 | |
| 8 | 2021 | 7 | |
| 9 | 1983 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 1984 | 2 |
About Mary E. Bradley
Mary E. Bradley is a scholar working on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Parasitology and Organic Chemistry, having authored 11 papers that have together received 475 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (2 papers), Fungal Infections and Studies (2 papers), Aquaculture disease management and microbiota (1 paper), Alcoholism and Thiamine Deficiency (1 paper), Amoebic Infections and Treatments (1 paper), Toxoplasma gondii Research Studies (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (47 citations), Infectious Diseases (265 citations), Clinical Biochemistry (48 citations), Epidemiology (176 citations) and Critical Care and Intensive Care Medicine (18 citations). Mary E. Bradley has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Oliver H. Lowry, Helen B. Burch, Peter G. Pappas, Virginia L. Kan, Daniel H. Kett, William E. Dismukes, Barbara D. Alexander, Samuel Major, John Rex and Carole A. Sable. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Biological Chemistry, Cellular and Molecular Life Sciences, Canadian Journal of Microbiology and Annals of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.